QR Code

CHANGES IN DNA METHYLATION PROFILE IN TAMOXIFEN-RESISTANT MCF-7 SUBLINES

Abstract Introduction. We have previously shown the feasibility of hormonal resistance horizontal distribution from cell to cell, with the joint cultivation of sensitive and resistant cells and/or through exosomes secreted by resistant cells. What is the mechanism of such resistance distribution, an...

Full description

Saved in:

Bibliographic Details
Main Authors:	О. Е. Andreeva, V. О. Sigin, V. V. Strelnikov, A. S. Tanas, A. M. Scherbakov, M. A. Krasilnikov
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2019-11-01
Series:	Сибирский онкологический журнал
Subjects:	breast cancer tamoxifen exosomes hormonal resistance methylation
Online Access:	https://www.siboncoj.ru/jour/article/view/1187
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COMPARATIVE ANALYSIS OF THE EXOSOMAL CARGO OF THE ESTROGEN-RESISTANT BREAST CANCER CELLS
by: S. E. Semina, et al.
Published: (2018-09-01)

Intercellular interactions and progression of hormonal resistance of breast cancer cells
by: S. E. Semina, et al.
Published: (2015-06-01)

ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE
by: D. B. Erdyneeva, et al.
Published: (2020-09-01)

Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer
by: A. Yu. Goryainova, et al.
Published: (2023-05-01)

Tamoxifen Molecular Targets Different From Estrogen Receptors
by: T. A. Bogush, et al.
Published: (2020-05-01)

Multimodal Imaging of Varied Presentation of Tamoxifen Maculopathy
by: Pushpanjali Badole, et al.
Published: (2025-04-01)

Ultrasonic, hysteroscopic and histological evaluation of the endometrium in women receiving tamoxifen for breast cancer
by: N. S. Melnikova, et al.
Published: (2014-07-01)

Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
by: Jaime D. Lewis, et al.
Published: (2014-11-01)

Features of ultrasound of endometrial pathological conditions in breast cancer patients receiving tamoxifen: a review of literature
by: M. A. Chekalova, et al.
Published: (2020-06-01)

Effect of the exosome-mediated suppression of the estrogen signaling: the role in the progression of the hormonal resistance of breast cancer cells
by: D. V. Sorokin, et al.
Published: (2020-11-01)

Current Endocrine Therapy in Hormone-Receptor-Positive Breast Cancer: From Tumor Biology to the Rationale for Therapeutic Tunning
by: Oana Maria Burciu, et al.
Published: (2025-07-01)

Nebivolol Mitigate the Hepatic Expression Level of Inducible and Endothelial Nitric Oxide Synthase in Tamoxifen-Induced Oxido-Inflammatory Changes in Female Rats
by: Noor Ahmed Hammadi, et al.
Published: (2025-06-01)

New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy
by: T. A. Bogush, et al.
Published: (2020-05-01)

THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF EARLY-STAGE HORMONE-SENSITIVE BREAST CANCER
by: I. A. Koroleva, et al.
Published: (2018-08-01)

Individual approach to choosing an appropriate regimen of adjuvant hormone therapy in patients with early-stage breast cancer
by: E. M. Slonimskaya, et al.
Published: (2018-10-01)

Methods of DNa methylation analysis:possibilities and limitations of their application in oncology
by: N. A. Skryabin, et al.
Published: (2016-02-01)

MicroRNA-484 / Akt axis in the regulation of breast cancer cells sensitivity to antitumor drugs
by: O. E. Andreeva, et al.
Published: (2022-12-01)

CYP2D6-GENOTYPING IN THE ASSESSMENT OF THE EFFECTIVENESS OF THERAPY WITH TAMOXIFEN IN PATIENTS WITH ADVANCED HORMONE RECEPTOR-POSITIVE BREAST CANCER
by: L. N. Lyubchenko, et al.
Published: (2017-12-01)

Ten-year adjuvant hormone therapy for breast cancer: the pros and cons (a review of literature)
by: S. M. Portnoy, et al.
Published: (2014-07-01)

METHYLATION OF CELLULAR DNA AND PATHOLOGY OF THE ORGANISM
by: V. A. Kozlov
Published: (2014-07-01)

The multidrug resistance proteins Pgp, MRP, and BCRP as markers for lowering the efficacy of tamoxifen in the treatment of breast cancer
by: T. A. Bogush, et al.
Published: (2014-07-01)

Continuous ultraviolet irradiation induces the development of irreversible resistance of melanoma cells to anticancer drugs
by: Yu. Yu. Shchegolev, et al.
Published: (2023-10-01)

CYP2D6 genotype and outcome in tamoxifen treated early breast cancer
by: Linda Thorén, et al.
Published: (2025-07-01)

DNA Methylation, Aging, and Cancer
by: Himani Vaidya, et al.
Published: (2025-06-01)

The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cells
by: O. E. Andreeva, et al.
Published: (2023-12-01)

Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer
by: T. A. Dronova, et al.
Published: (2018-11-01)

Advancements in DNA methylation technologies and their application in cancer diagnosis
by: Yang Yang, et al.
Published: (2025-12-01)

DNA methylation abnormalities in atherosclerosis
by: Samira Tabaei, et al.
Published: (2019-12-01)

Generation of the MCF-7 cell sublines with CRISPR/Cas9 mediated disruption of estrogen receptor alfa (ESR1) expression
by: L. O. Savinska, et al.
Published: (2024-12-01)

The role of DNA methylation in the disorders of bone metabolism
by: B. I. Yalaev, et al.
Published: (2019-02-01)

Research Progress of DNA Methylation in Fish
by: Hai HUANG, et al.
Published: (2025-08-01)

EXOSOMES AND DEVELOPMENT OF TUMOR CELL RESISTANT PHENOTYPE
by: M. A. Krasilnikov, et al.
Published: (2018-05-01)

DNA methylation in esophageal cancer: technological advances and early detection clinical applications
by: Jiyu Tang, et al.
Published: (2025-07-01)

Integration of phosphoinositide 3-kinase (PI3K) and transforming growth factor β1 (TGF-β1) signaling cascades: role in the therapeutic inefficiency of tamoxifen
by: N. N. Babyshkina, et al.
Published: (2023-12-01)

COMORBIDITY, DNA METHYLATION AND AUTOIMMUNITY IN DIABETES-ASSOCIATED OSTEOARTHRITIS: AN EXPLORATORY STUDY
by: I. V. Shirinsky, et al.
Published: (2015-10-01)

Immune DNA methylation in depression: cross-sectional and longitudinal study
by: Marisol Herrera-Rivero, et al.
Published: (2025-07-01)

Aberrations of DNA methylation in cancer
by: V. P. Maksimova, et al.
Published: (2022-12-01)

Approaches to anticancer therapy based on modulation of DNA methylation
by: V. P. Maksimova, et al.
Published: (2024-09-01)

EXTRACELLULAR DNA AND THE LEVEL OF ITS METHYLATION IN DIFFERENT RHEUMATIC DISEASES
by: N O Shubayeva, et al.
Published: (2012-02-01)

Estrogen Receptor Expression in Tumors Different from Breast Cancer
by: T. A. Bogush, et al.
Published: (2020-05-01)